Purchase Order HT942726PE011
- Not listed
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization, to provide bioassay testing services. The contract has a ceiling value of $29,623.68 and a period of performance through December 19, 2023. The services under this contract will include testing of operational medications such as epinephrine, norepinephrine, and vasopressin, which are critical for military medical readiness. Eurofins...
- <p>The Defense Health Agency issued a purchase order to Government Scientific Source Inc., a small business, for chemistry testing on October 1, 2023, with a ceiling value of $1,912,524.07. This modification de-obligates excess FY24 and FY25 funds to reflect actual amounts used during performance. Performance occurs at Fort Sam Houston, Texas. The order is firm fixed price with an ultimate completion date of September 30, 2028.</p>
- <p>The Department of Defense Medical Supply Chain issued a $1,985 delivery order to Fisher Scientific Company L.L.C. on April 14, 2026, for serum toxicology testing reagents and triage supplies.</p> <p>This delivery order is issued under a fixed-price contract with economic price adjustment. Place of performance is Pittsburgh, PA 15275. The ultimate completion date is April 28, 2026.</p>
- <p>The Defense Health Agency's Medical Supply Chain division issued a $1,335.54 delivery order to VWR International LLC on April 1, 2026, for arsenic limit testing under a fixed-price contract with economic price adjustment provisions. The order is due for ultimate completion on April 22, 2026.</p> <p>Place of performance is Wayne, PA 19087. The order carries no set-aside designation.</p>
- The Defense Health Agency awarded a purchase order to Qualtex Laboratories on May 1, 2023, for blood donor testing services valued at $1,907,678.98 through April 30, 2028. No set-aside was used. Performance occurs in San Antonio, Texas. The order procures FDA-licensed blood donor testing for reportable infectious diseases, including standard and confirmatory testing, supporting the Armed Services Blood Bank Center – Europe at Landstuhl Regional Medical Center, Germany. The contract is firm fixed...
- <p>The Defense Logistics Agency (via its Medical Supply Chain entity) issued a $2,944 delivery order to Fisher Scientific Company L.L.C. on April 17, 2026, for reagent toxicology methadone metabolite testing supplies, with an ultimate completion date of April 24, 2026.</p> <p>Place of performance is Pittsburgh, PA. The order is priced as fixed price with economic price adjustment and carries no set-aside designation.</p>
- The Defense Health Agency awarded a firm fixed price purchase order valued at eleven thousand four hundred ninety-eight dollars to Eurofins EPK Built Environment Testing, LLC, doing business as Test America, to provide laboratory analytical support services. Performance will take place in Killeen, Texas, with no set-aside designation applied. Eurofins EPK Built Environment Testing is a foreign owned, for-profit organization that will support the Defense Health Agency's laboratory testing needs...
- <p>The Defense Health Agency awarded a purchase order to B. French Consulting GMBH for laboratory technician services, valued at $399,319.68, with an award date of May 1, 2025. Performance takes place in Germany, with work concluding by April 30, 2030. The order is firm fixed price with no small business set-aside.</p>
- The Defense Health Agency awarded a purchase order to Fisher Scientific Company L.L.C. (operating as Fisher Healthcare) for $183,248.59 on October 15, 2024, for lab supplies, with ultimate completion scheduled for October 14, 2029. The order is firm fixed price with no set-aside category. Work is performed in Norfolk, Virginia. The purchase order covers laboratory consumables and supplies supporting federal healthcare operations, consistent with Fisher Healthcare's portfolio of diagnostic and...
- The Defense Health Agency awarded a purchase order to Creative Testing Solutions for $3,559,875 on October 1, 2025, to provide infectious disease testing for the Armed Services Blood Donation Program at Fort Leonard Wood, Missouri, through September 30, 2030. The order is firm fixed price with no small business set-aside. Testing services include screening for bloodborne pathogens including HIV, hepatitis, syphilis, and other infectious diseases to support military blood donor operations at...
The Defense Health Agency awarded a purchase order to Eurofins Analytics, LLC for hazardous drug sample analysis services valued at $60,000.00 with an award date of May 1, 2026 and ultimate completion date of April 30, 2027. Performance occurs in Ashland, Virginia. The order calls for laboratory analysis of chemotherapy-related hazardous drugs (5-Fluorouracil, Methotrexate, Ifosfamide, Cyclophosphamide Monohydrate, Doxorubicin Hydrochloride, and Paclitaxel) from wipe and swab samples collected at Military Treatment Facilities and pharmacies. The contractor must maintain ISO/IEC 17025 accreditation, meet 15-calendar-day turnaround for standard priority and 8-calendar-day turnaround for high-priority samples, comply with USP 800 and TB-MED 515 regulatory standards, provide a Quality Control Plan, and submit weekly status reports and monthly financial tracking. The government supplies all samples and testing wipes; the contractor furnishes facilities, equipment, and sample disposal. The originating solicitation was posted April 16, 2026 with a due date of April 24, 2026.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Hazardous Drug Sample Analysis | HT942726QE008 | None | Award Notice 2/2 | 4/30/26, 10:06 AM | |
Hazardous Drug Sample Analysis | HT942726QE008 | None | Solicitation 1/2 | 4/16/26, 11:29 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.0k | 4/29/26 |